Brian Lu

2.4k citations
56 papers · 1.6k · 1 hit paper · h-index 20

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 26
    • Cancer Treatment and Pharmacology 8
    • Colorectal Cancer Treatments and Studies 5
    • Cancer Genomics and Diagnostics 16

Brian Lu

53 papers receiving 1.6k citations

Brian Lu's Hit Papers

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial 2015 · 523 citations
5230+3+7Years since publication100200300400500

Peers

Brian Lu
Comparison fields: 5 of 102
  • Oncology 871
  • Cancer Research 268
  • Pulmonary and Respiratory Medicine 211
  • Molecular Biology 486
  • Epidemiology 169
Replace Ru Jia with:
Ru Jia China
Takanori Goi Japan
Kenji Tsuchihashi Japan
Esther Bertrán Spain
Manuela Sarti Italy
Lui Ng Hong Kong
Libo Chen China
Elvira Olaso Spain
Dung‐Tsa Chen United States
Iwao Takanami Japan
Brian Lu relative to Ru Jia China Ru Jia's profile →
Citations per field
00.5×2.7×
Ru Jia · 1×
Citations per year

Countries citing papers authored by Brian Lu

Since Specialization
Citations

This map shows the geographic impact of Brian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Lu more than expected).

Fields of papers citing papers by Brian Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Lu. The network helps show where Brian Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Lu Line = papers co-authored together Brian Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
Hit paper breakdown →
2015523
2 201998
3 199891
4 202087
5 201681
6 199777
7 201677
8 201666
9 199947
10 201547
11 201636
12 202135
13 201534
14 201428
15 201126
16 201821
17 201621
18 201721
19 201721
20 201419

About Brian Lu

Brian Lu is a scholar working on Oncology, Cancer Research, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (26 papers), Cancer Genomics and Diagnostics (16 papers), Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (5 papers), Pancreatic function and diabetes (5 papers), Diabetes and associated disorders (4 papers), Renal cell carcinoma treatment (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Oncology (871 citations), Cancer Research (268 citations), Pulmonary and Respiratory Medicine (211 citations), Molecular Biology (486 citations) and Epidemiology (169 citations). Brian Lu has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include David Goldstein, Josep Tabernero, Daniel D. Von Hoff, Volker Kunzmann, Giampaolo Tortora, Alfredo Romano, Robert H. El-Maraghi, Jean‐Luc Van Laethem, Salvatore Siena and Luís Teixeira. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Cell Biology, Pancreas and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact